CSTL

Daniel Bradbury

Known title: DirectorCIK: 0001236397

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Castle Biosciences to Release Q3 2026 Results and New Barrett's Data. Castle Biosciences announced it will release its third‑quarter 2026 financial results on Thursday, November 5, and will host a webcast. The company also plans to present new data from three studies on its TissueCypher Barrett’s Esophagus test at the ACG 2026 annual scientific meeting, showing the test can identify elevated risk of progression beyond pathology findings. These updates give the market fresh information on both the company's earnings and the clinical relevance of its main product.

this person other insiders at CSTL

Transaction History

CSTL▲ Buy—
CSTL▲ Buy—
CSTL▼ Sell$141K
CSTL▼ Sell$40K
CSTL▼ Sell$40K
CSTL▼ Sell$4K
CSTL▼ Sell$89K
CSTL▼ Sell$25K
CSTL▼ Sell$25K
CSTL▼ Sell$14K
CSTL▼ Sell$4K
CSTL▼ Sell$43K
CSTL▼ Sell$12K
CSTL▼ Sell$12K
CSTL▼ Sell$145K
CSTL▼ Sell$41K
CSTL▼ Sell$41K
CSTL▼ Sell$11K
CSTL▼ Sell$3K
CSTL▼ Sell$3K
CSTL▼ Sell$45K
CSTL▼ Sell$13K
CSTL▼ Sell$13K
CSTL▼ Sell$94K
CSTL▼ Sell$27K
CSTL▼ Sell$27K
CSTL▼ Sell$36K
CSTL▼ Sell$10K
CSTL▼ Sell$10K
CSTL▼ Sell$148K
CSTL▼ Sell$42K
CSTL▼ Sell$42K
CSTL▼ Sell$146K
CSTL▼ Sell$41K
CSTL▼ Sell$41K
CSTL▼ Sell$134K
CSTL▼ Sell$38K
CSTL▼ Sell$38K
CSTL▲ Buy—
CSTL▼ Sell$182K
CSTL▼ Sell$196K
CSTL▼ Sell$196K
CSTL▼ Sell$17K
CSTL▼ Sell$16K
CSTL▼ Sell$17K
CSTL▼ Sell$78K
CSTL▼ Sell$84K
CSTL▼ Sell$84K
CSTL▼ Sell$62K
CSTL▼ Sell$67K
CSTL▼ Sell$67K
CSTL▼ Sell$108K
CSTL▼ Sell$117K
CSTL▼ Sell$117K
CSTL▼ Sell$45K
CSTL▼ Sell$48K
CSTL▼ Sell$48K
CSTL▼ Sell$15K
CSTL▼ Sell$16K
CSTL▼ Sell$16K
CSTL▼ Sell$79K
CSTL▼ Sell$79K
CSTL▼ Sell$74K
CSTL▼ Sell$63K
CSTL▼ Sell$67K
CSTL▼ Sell$67K
CSTL▼ Sell$20K
CSTL▼ Sell$22K
CSTL▼ Sell$22K
CSTL▼ Sell$35K
CSTL▼ Sell$33K
CSTL▼ Sell$35K
CSTL▼ Sell$118K
CSTL▼ Sell$127K
CSTL▼ Sell$127K
CSTL▼ Sell$7K
CSTL▼ Sell$8K
CSTL▼ Sell$8K
CSTL▼ Sell$8K
CSTL▼ Sell$8K
CSTL▼ Sell$8K
CSTL▼ Sell$44K
CSTL▼ Sell$47K
CSTL▼ Sell$47K
CSTL▼ Sell$1K
CSTL▼ Sell$1K
CSTL▼ Sell$1K
CSTL▼ Sell$28K
CSTL▼ Sell$30K
CSTL▼ Sell$30K
CSTL▼ Sell$61K
CSTL▼ Sell$65K
CSTL▼ Sell$65K
CSTL▼ Sell$49K
CSTL▼ Sell$49K
CSTL▼ Sell$147K
CSTL▼ Sell$209K
CSTL▼ Sell$70K
CSTL▼ Sell$70K
CSTL▼ Sell$3K
CSTL▼ Sell$3K
CSTL▼ Sell$10K
CSTL▼ Sell$4K
CSTL▼ Sell$1K
CSTL▼ Sell$1K
CSTL▼ Sell$23K
CSTL▼ Sell$69K
CSTL▼ Sell$23K
CSTL▼ Sell$22K
CSTL▼ Sell$7K
CSTL▼ Sell$7K
CSTL▼ Sell$88K
CSTL▼ Sell$29K
CSTL▼ Sell$29K
CSTL▼ Sell$56K
CSTL▼ Sell$19K
CSTL▼ Sell$19K
CSTL▼ Sell$612K
CSTL▼ Sell$204K
CSTL▼ Sell$204K
CSTL▲ Buy—
CSTL▼ Sell$17K
CSTL▼ Sell$43K
CSTL▼ Sell$14K
CSTL▼ Sell$14K
CSTL▼ Sell$52K
CSTL▼ Sell$17K
CSTL▼ Sell$72K
CSTL▼ Sell$24K
CSTL▼ Sell$24K
CSTL▼ Sell$157K
CSTL▼ Sell$52K
CSTL▼ Sell$52K
CSTL▼ Sell$95K
CSTL▼ Sell$32K
CSTL▼ Sell$32K
CSTL▼ Sell$101K
CSTL▼ Sell$34K
CSTL▼ Sell$34K
CSTL▼ Sell$46K
CSTL▼ Sell$137K
CSTL▼ Sell$46K
CSTL▼ Sell$67K
CSTL▼ Sell$201K
CSTL▼ Sell$67K
CSTL▼ Sell$53K
CSTL▼ Sell$106K
CSTL▼ Sell$35K
CSTL▼ Sell$18K
CSTL▼ Sell$35K
CSTL▼ Sell$18K
CSTL▼ Sell$77K
CSTL▼ Sell$26K
CSTL▼ Sell$26K
CSTL▼ Sell$12K
CSTL▼ Sell$4K
CSTL▼ Sell$4K
CSTL▼ Sell$67K
CSTL▼ Sell$122K
CSTL▼ Sell$41K
CSTL▼ Sell$41K
CSTL▼ Sell$201K
CSTL▼ Sell$67K
CSTL▼ Sell$160K
CSTL▼ Sell$16K
CSTL▼ Sell$185K
CSTL▼ Sell$165K
CSTL▼ Sell$31K
CSTL▼ Sell$99K
CSTL▼ Sell$111K
CSTL▼ Sell$216K
CSTL▼ Sell$212K
CSTL▲ Buy$0
CSTL▲ Buy—
CSTL▼ Sell$170K
CSTL▼ Sell$90K
CSTL▼ Sell$23K
CSTL▼ Sell$115K
CSTL▼ Sell$173K
CSTL▼ Sell$114K
CSTL▼ Sell$115K
CSTL▼ Sell$129K
CSTL▼ Sell$13K
CSTL▼ Sell$91K
CSTL▼ Sell$91K
CSTL▼ Sell$90K
CSTL▼ Sell$60K
CSTL▼ Sell$93K
CSTL▼ Sell$95K
CSTL▼ Sell$150K
CSTL▼ Sell$98K
CSTL▼ Sell$99K
CSTL▼ Sell$149K
CSTL▼ Sell$98K
CSTL▼ Sell$99K
CSTL▼ Sell$150K
CSTL▼ Sell$21K
CSTL▼ Sell$115K
CSTL▼ Sell$116K
CSTL▼ Sell$178K

We use analytics to understand how market-wall is used. No personal data is sold.